Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


FDA Approves Botox for Overactive Bladder
When patients don't respond to standard treatments
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

August 27, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Restrictive, Non-Solicitation Covenants Are Valid

Organizations Can Help Docs Retain Their Independence

HTN Self-Management Beneficial in High-Risk Patients

U.S. to Tighten Access to Certain Narcotic Painkillers

Ban Indoor Use of E-Cigarettes, U.N. Health Agency Says

FDA: Steer Clear of Dietary Supplements for Concussions